Amtek

Amtek: DBSV notes 3Q12 results came in below expectations, as sales and margins fell short. Expects broad based weakness to persist near term, with DPS likely to decine alongside lower profits. Cuts FY13/14e earnings by 3-%, lowers TP to $0.46 from $0.66. Downgrades to Fully Valied on lower TP and dividend.